- Category: Business
Business
Leadership watch: Haag-Stret, Heidelberg, and Samsara name new executives
Check out the latest leadership news from the eyecare space, including a new CEO at Haag-Streit and other major appointments.Business
Neurolens debuts official rebrand as Newton
Maker of the first and only therapeutic lenses clinically proven to relieve eye misalignment symptoms announces next chapter in its eyecare journey.Business
Topcon invests in Senseye's ocular biomarker-based mental health platform
First app of its kind utilizes the eye as a non-invasive window to the brain to identify neuropsychiatric conditions—in just 15 minutes.Business
OpZira launches with LumiThera diagnostic product line
Spin-off company official forms following Alcon-LumiThera acquisition to offer two ophthalmic products: the AdaptDx Pro and NOVA Vision Testing System.Business
Alcon officially purchases LumiThera
Acquisition of the Valeda Light Delivery System includes plans to expand commercial market availability in 2026.Business
Barti raises $12M to support expansion of AI-based eyecare EHR
Financing to further advance software company’s advancement toward integration in ophthalmology and development of new automated, AI-embedded offerings.Business
Leadership watch: J&J and Rebion appoint new executives
Business
Opthea to lay off 80% of workforce amid executive cuts
Company also announces cuts to Board of Directors as the CEO is among several planned departures beginning in September.Business
Updated reciprocal tariffs to take effect this week
With new rates hitting Aug. 7, take a look at how the optical industry will be impacted as top trade partners face an increase on U.S. imports.Business
Alcon to acquire STAAR Surgical
The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.Business
Topcon acquires Intelligent Retinal Imaging Systems
As part of theBusiness
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.Business
Topcon invests in OKKO Health's home vision monitoring platform
The OKKO Health app is available on patients’ digital devices to enable ongoing self-monitoring of macular degeneration.Business
Clearside exploring options to advance suprachoroidal delivery platform
Company pauses all other research programs, transitions employees to consulting roles, and shares phase 3 plans for wet AMD candidate while focusing on the SCS Microinjector.Business
Harrow purchases US commercialization rights to Samsung Bioepis' biosimilar portfolio
Acquisition includes two major anti-VEGF therapies for retinal diseases: OPUVIZ and BYOOVIZ, generic equivalents to EYLEA and Lucentis, respectively.Business
Meta reportedly buys minority stake in EssilorLuxottica
The estimated $3.51 billion investment follows companies’ recent plans to launch AI-powered smart glasses for the Oakley sports performance frames this summer.Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.Business
4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program
Company reports streamlined planning to advance phase 3 clinical trials of 4D-150, under evaluation to deliver a single, low-dose, and sustained multi-year intravitreal injection.Business
Alcon to purchase LumiThera
Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.Business